Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
0.7150
+0.0005 (0.07%)
Nov 11, 2026, 4:00 PM EST - Market closed
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $2.88 million as of November 11, 2026. It is the 46,857th most valuable company in the world and the 6,210th biggest in the United States. Its market cap has increased by 30.88% in one year.
Market Cap
2.88M
Enterprise Value
-1.95M
1-Year Change
30.88%
Global Rank
Country Rank
#6,210 United States
Category
ChartMarket Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $2.88M, a decrease of -95.00%. That is a compound annual growth rate of -43.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 2.88M | -53.40% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Azitra | 3.64M |
| Traws Pharma | 3.46M |
| Mustang Bio | 3.41M |
| Silo Pharma | 3.35M |
| KALA BIO | 3.31M |
| Ernexa Therapeutics | 3.28M |
| Jupiter Neurosciences | 2.93M |
| Aptevo Therapeutics | 2.88M |